EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial

Lucie Joerg, Kayla Zafar, Margaret Kabakova, Jennifer Y Wang, Julia Stolyar, Jenna Zudell, Jared Jagdeo

Journal of Drugs in Dermatology · 2026

DOI: 10.36849/jdd.10040 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Lucie Joerg und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Rosacea, Skin Cream, Sulfides, Tosyl Compounds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaSkin CreamSulfidesTosyl CompoundsHumansFemaleMaleMiddle AgedPilot ProjectsTreatment OutcomeAdultAgedAdministration, CutaneousQuality of LifeSebaceous GlandsPatient Reported Outcome MeasuresCortodoxonePropionates

Substanzen

ClascoteroneSulfidesTosyl CompoundsCortodoxonePropionates

Zitieren

APA

Joerg, L., Zafar, K., Kabakova, M., Wang, J. Y., Stolyar, J., Zudell, J., & Jagdeo, J. (2026). Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.10040

Vancouver

Joerg L, Zafar K, Kabakova M, Wang JY, Stolyar J, Zudell J, et al. Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.10040

BibTeX
@article{Joerg2026,
  author = {Joerg, Lucie and Zafar, Kayla and Kabakova, Margaret and Wang, Jennifer Y and Stolyar, Julia and Zudell, Jenna and Jagdeo, Jared},
  title = {Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  doi = {10.36849/jdd.10040}
}
Kostenlos starten →